AK5 | Adenylate kinase 5 | Enzymes
| | | | | Tissue enriched |
CAMK2A | Calcium/calmodulin-dependent protein kinase II alpha | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
DLGAP3 | Discs, large (Drosophila) homolog-associated protein 3 | | | | | | Group enriched |
FABP7 | Fatty acid binding protein 7, brain | | | | | | Tissue enriched |
NXPH2 | Neurexophilin 2 | Predicted secreted proteins
| | | | | Group enriched |
PPP1R17 | Protein phosphatase 1, regulatory subunit 17 | | | | | | Group enriched |
SH3GL3 | SH3-domain GRB2-like 3 | | | | | | Group enriched |
SYT14 | Synaptotagmin XIV | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
ZIC2 | Zic family member 2 | Disease related genes Plasma proteins Transcription factors
| | | | | Group enriched |
ADD2 | Adducin 2 (beta) | Cytoskeleton related proteins
| | | | | Group enriched |
ELMOD1 | ELMO/CED-12 domain containing 1 | Cytoskeleton related proteins Predicted membrane proteins
| | | | | Group enriched |
FAM181B | Family with sequence similarity 181, member B | | | | | | Tissue enriched |
GPR62 | G protein-coupled receptor 62 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
KCNC1 | Potassium voltage-gated channel, Shaw-related subfamily, member 1 | FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
RASGRF1 | Ras protein-specific guanine nucleotide-releasing factor 1 | RAS pathway related proteins
| | | | | Group enriched |
RPH3A | Rabphilin 3A homolog (mouse) | | | | | | Tissue enriched |
SYT11 | Synaptotagmin XI | | | | | | Tissue enriched |
ACTL6B | Actin-like 6B | | | | | | Tissue enriched |
CADM2 | Cell adhesion molecule 2 | Predicted membrane proteins
| | | | | Tissue enriched |
DSCAM | Down syndrome cell adhesion molecule | Plasma proteins Predicted membrane proteins
| | | | | Tissue enriched |
FAM131B | Family with sequence similarity 131, member B | | | | | | Tissue enriched |
KCNH1 | Potassium voltage-gated channel, subfamily H (eag-related), member 1 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
NAT8L | N-acetyltransferase 8-like (GCN5-related, putative) | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
SLC1A3 | Solute carrier family 1 (glial high affinity glutamate transporter), member 3 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC35F1 | Solute carrier family 35, member F1 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC6A1 | Solute carrier family 6 (neurotransmitter transporter), member 1 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SV2A | Synaptic vesicle glycoprotein 2A | FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
AQP4 | Aquaporin 4 | Predicted membrane proteins Transporters
| | | | | Group enriched |
ATCAY | Ataxia, cerebellar, Cayman type | Disease related genes
| | | | | Tissue enriched |
CEND1 | Cell cycle exit and neuronal differentiation 1 | Predicted membrane proteins
| | | | | Tissue enriched |
HTR2A | 5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
KCNC2 | Potassium voltage-gated channel, Shaw-related subfamily, member 2 | FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
MDGA2 | MAM domain containing glycosylphosphatidylinositol anchor 2 | Predicted membrane proteins
| | | | | Group enriched |
NRGN | Neurogranin (protein kinase C substrate, RC3) | | | | | | Tissue enriched |
PRKCG | Protein kinase C, gamma | Disease related genes Enzymes Potential drug targets RAS pathway related proteins
| | | | | Tissue enriched |
SHISA7 | Shisa family member 7 | Predicted membrane proteins
| | | | | Tissue enriched |
TMEM88B | Transmembrane protein 88B | Predicted membrane proteins
| | | | | Tissue enriched |
AMPH | Amphiphysin | Cancer-related genes
| | | | | Tissue enriched |
B3GAT1 | Beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P) | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
BAI2 | Brain-specific angiogenesis inhibitor 2 | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
CMTM5 | CKLF-like MARVEL transmembrane domain containing 5 | Predicted membrane proteins
| | | | | Tissue enriched |
GAD1 | Glutamate decarboxylase 1 (brain, 67kDa) | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enriched |
MAP2 | Microtubule-associated protein 2 | FDA approved drug targets Plasma proteins
| | | | | Tissue enriched |
NEUROD1 | Neuronal differentiation 1 | Disease related genes Transcription factors
| | | | | Group enriched |
PGM2L1 | Phosphoglucomutase 2-like 1 | Enzymes
| | | | | Tissue enriched |
SCG3 | Secretogranin III | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
SERPINI1 | Serpin peptidase inhibitor, clade I (neuroserpin), member 1 | Disease related genes Predicted secreted proteins
| | | | | Tissue enriched |
SH3GL2 | SH3-domain GRB2-like 2 | | | | | | Tissue enriched |
SMIM18 | Small integral membrane protein 18 | Predicted membrane proteins
| | | | | Tissue enriched |
SPHKAP | SPHK1 interactor, AKAP domain containing | | | | | | Group enriched |